drugset / Trial / NCT01029782
Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
Phase 2
Completed
206 enrolled
Kelowna General Hospital
Canadian Society of Hospital Pharmacists · collabCapital Health, Canada · collabInterior Health Authority, Canada · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether oral cephalexin is equivalent to intravenous cefazolin plus oral probenecid for the treatment of uncomplicated skin and soft tissue infections in patients that present to the emergency department.
Timeline
- Start
- 2010-05
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CEPHALEXIN ANHYDROUS | Small molecule | 500 mg | Oral |
| Comparator | Cefazolin | Small molecule | 2 g | Intravenous |
| Comparator | Probenecid | Small molecule | 1 g | Oral |